The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8598217, 164 ID: ALA3660200
PubChem CID: 67292550
Max Phase: Preclinical
Molecular Formula: C25H21N7O
Molecular Weight: 435.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccnc(-c2cncc3ccccc23)c1)c1nc2nc(N3CCNCC3)ccc2[nH]1
Standard InChI: InChI=1S/C25H21N7O/c33-23(25-29-20-5-6-22(30-24(20)31-25)32-11-9-26-10-12-32)16-7-8-28-21(13-16)19-15-27-14-17-3-1-2-4-18(17)19/h1-8,13-15,26H,9-12H2,(H,29,30,31)
Standard InChI Key: WPTQTLKVJWJUIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 38 0 0 0 0 0 0 0 0999 V2000
4.9261 -5.8568 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8888 -5.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5868 -5.9998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4415 -7.4799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9734 -7.7839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2168 -9.0792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2831 -9.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0265 -7.7688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2700 -6.4735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2300 -6.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2386 -5.3719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0401 -10.3675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2988 -11.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0574 -12.9656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5574 -12.9556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2987 -11.6516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5401 -10.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
7 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 9 1 0
18 13 1 0
2 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
26 27 1 0
27 19 1 0
23 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.49Molecular Weight (Monoisotopic): 435.1808AlogP: 3.21#Rotatable Bonds: 4Polar Surface Area: 99.69Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.08CX Basic pKa: 8.42CX LogP: 2.42CX LogD: 1.61Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -0.91
References 1. (2013) Imidazole derivatives and their use as modulators of cyclin dependent kinases,